A new regulation (Regulation (EU) 2020/1204) including the dicofol in the Annex I of the POPs Regulation has been published in the Official Journal.

The substance presents in the Annex I POPs Regulation are subject to prohibition (with specific exemptions) on manufacturing, placing on the market and use.